AG˹ٷ

STOCK TITAN

[Form 4] Amedisys Inc Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

On 07/29/2025 Orrstown Financial Services (ORRF) filed a Form 4 for EVP & Chief Experience Officer Michael Jaeger. The executive sold 642 common shares on 07/28/2025 at $34.25 (transaction code “S�). After the sale, Jaeger directly owns 745 unrestricted shares and 4,198 restricted shares that vest over the next three years.

No derivative securities were involved and no purchases were reported. The disposition reduced Jaeger’s freely tradable stake by roughly 46 % (642 of 1,387 previously held). No other insiders are covered in this filing.

Il 29/07/2025 Orrstown Financial Services (ORRF) ha presentato un Modulo 4 per EVP e Chief Experience Officer Michael Jaeger. Il dirigente ha venduto 642 azioni ordinarie il 28/07/2025 al prezzo di $34,25 (codice transazione “S�). Dopo la vendita, Jaeger possiede direttamente 745 azioni senza restrizioni e 4.198 azioni vincolate che matureranno nei prossimi tre anni.

Non sono stati coinvolti titoli derivati né sono stati segnalati acquisti. La cessione ha ridotto la quota liberamente negoziabile di Jaeger di circa il 46% (642 su 1.387 precedentemente detenute). Nessun altro insider è incluso in questa comunicazione.

El 29/07/2025 Orrstown Financial Services (ORRF) presentó un Formulario 4 para el EVP y Chief Experience Officer Michael Jaeger. El ejecutivo vendió 642 acciones comunes el 28/07/2025 a $34,25 (código de transacción “S�). Después de la venta, Jaeger posee directamente 745 acciones sin restricciones y 4.198 acciones restringidas que se liberarán durante los próximos tres años.

No se involucraron valores derivados ni se reportaron compras. La disposición redujo la participación libremente negociable de Jaeger en aproximadamente un 46 % (642 de 1.387 anteriormente poseídas). Ningún otro insider está incluido en esta presentación.

2025� 7� 29� Orrstown Financial Services(ORRF)� EVP � 최고 경험 책임� Michael Jaeger� 대� Form 4� 제출했습니다. 해당 임원은 2025� 7� 28일에 642� 보통주를 주당 $34.25� 매도했습니다(거래 코드 “S�). 매도 � Jaeger� 직접 제한 없는 745�와 향후 3년간 권리가 발생하는 4,198� 제한 주식� 보유하고 있습니다.

파생 증권은 포함되지 않았으며 매수 신고� 없었습니�. 이번 매도� Jaeger� 자유롭게 거래 가능한 지분이 � 46% 감소했습니다(기존 1,387� � 642� 매도). � 제출서류에는 다른 내부� 정보가 포함되어 있지 않습니다.

Le 29/07/2025, Orrstown Financial Services (ORRF) a déposé un formulaire 4 pour le EVP et Chief Experience Officer Michael Jaeger. Le dirigeant a vendu 642 actions ordinaires le 28/07/2025 au prix de 34,25 $ (code de transaction « S »). Après la vente, Jaeger détient directement 745 actions sans restriction et 4 198 actions restreintes qui seront acquises au cours des trois prochaines années.

Aucun titre dérivé n’a été impliqué et aucun achat n’a été signalé. La cession a réduit la part librement négociable de Jaeger d’environ 46 % (642 sur 1 387 détenues précédemment). Aucun autre initié n’est concerné par ce dépôt.

Am 29.07.2025 reichte Orrstown Financial Services (ORRF) ein Formular 4 für EVP und Chief Experience Officer Michael Jaeger ein. Der Geschäftsführer verkaufte am 28.07.2025 642 Stammaktien zu je 34,25 $ (Transaktionscode „S�). Nach dem Verkauf besitzt Jaeger direkt 745 uneingeschränkte Aktien und 4.198 eingeschränkte Aktien, die in den nächsten drei Jahren freigegeben werden.

Es waren keine derivativen Wertpapiere beteiligt und keine Käufe wurden gemeldet. Die Veräußerung reduzierte Jaegers frei handelbaren Anteil um etwa 46 % (642 von zuvor 1.387 gehaltenen Aktien). In dieser Meldung sind keine weiteren Insider enthalten.

Positive
  • None.
Negative
  • EVP Michael Jaeger sold 642 shares at $34.25, reducing his direct unrestricted stake by ~46 %, a potential bearish insider-sentiment cue.

Insights

TL;DR: Small insider sale; limited float impact, mildly negative sentiment signal.

The 642-share sale equals about US$22k and only trims the executive’s position, leaving him with 745 unrestricted shares plus 4,198 restricted. That size is immaterial to ORRF’s ~11 m share float, so liquidity or valuation effects are negligible. However, insiders usually sell for many reasons, so a single, modest disposal offers a weak bearish signal rather than a decisive indicator. No derivative hedges or simultaneous buys are disclosed, keeping the read-through slightly negative but overall neutral in impact for investors.

Il 29/07/2025 Orrstown Financial Services (ORRF) ha presentato un Modulo 4 per EVP e Chief Experience Officer Michael Jaeger. Il dirigente ha venduto 642 azioni ordinarie il 28/07/2025 al prezzo di $34,25 (codice transazione “S�). Dopo la vendita, Jaeger possiede direttamente 745 azioni senza restrizioni e 4.198 azioni vincolate che matureranno nei prossimi tre anni.

Non sono stati coinvolti titoli derivati né sono stati segnalati acquisti. La cessione ha ridotto la quota liberamente negoziabile di Jaeger di circa il 46% (642 su 1.387 precedentemente detenute). Nessun altro insider è incluso in questa comunicazione.

El 29/07/2025 Orrstown Financial Services (ORRF) presentó un Formulario 4 para el EVP y Chief Experience Officer Michael Jaeger. El ejecutivo vendió 642 acciones comunes el 28/07/2025 a $34,25 (código de transacción “S�). Después de la venta, Jaeger posee directamente 745 acciones sin restricciones y 4.198 acciones restringidas que se liberarán durante los próximos tres años.

No se involucraron valores derivados ni se reportaron compras. La disposición redujo la participación libremente negociable de Jaeger en aproximadamente un 46 % (642 de 1.387 anteriormente poseídas). Ningún otro insider está incluido en esta presentación.

2025� 7� 29� Orrstown Financial Services(ORRF)� EVP � 최고 경험 책임� Michael Jaeger� 대� Form 4� 제출했습니다. 해당 임원은 2025� 7� 28일에 642� 보통주를 주당 $34.25� 매도했습니다(거래 코드 “S�). 매도 � Jaeger� 직접 제한 없는 745�와 향후 3년간 권리가 발생하는 4,198� 제한 주식� 보유하고 있습니다.

파생 증권은 포함되지 않았으며 매수 신고� 없었습니�. 이번 매도� Jaeger� 자유롭게 거래 가능한 지분이 � 46% 감소했습니다(기존 1,387� � 642� 매도). � 제출서류에는 다른 내부� 정보가 포함되어 있지 않습니다.

Le 29/07/2025, Orrstown Financial Services (ORRF) a déposé un formulaire 4 pour le EVP et Chief Experience Officer Michael Jaeger. Le dirigeant a vendu 642 actions ordinaires le 28/07/2025 au prix de 34,25 $ (code de transaction « S »). Après la vente, Jaeger détient directement 745 actions sans restriction et 4 198 actions restreintes qui seront acquises au cours des trois prochaines années.

Aucun titre dérivé n’a été impliqué et aucun achat n’a été signalé. La cession a réduit la part librement négociable de Jaeger d’environ 46 % (642 sur 1 387 détenues précédemment). Aucun autre initié n’est concerné par ce dépôt.

Am 29.07.2025 reichte Orrstown Financial Services (ORRF) ein Formular 4 für EVP und Chief Experience Officer Michael Jaeger ein. Der Geschäftsführer verkaufte am 28.07.2025 642 Stammaktien zu je 34,25 $ (Transaktionscode „S�). Nach dem Verkauf besitzt Jaeger direkt 745 uneingeschränkte Aktien und 4.198 eingeschränkte Aktien, die in den nächsten drei Jahren freigegeben werden.

Es waren keine derivativen Wertpapiere beteiligt und keine Käufe wurden gemeldet. Die Veräußerung reduzierte Jaegers frei handelbaren Anteil um etwa 46 % (642 von zuvor 1.387 gehaltenen Aktien). In dieser Meldung sind keine weiteren Insider enthalten.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Guidroz Allyson

(Last) (First) (Middle)
3854 AMERICAN WAY , SUITE A

(Street)
BATON ROUGE LA 70816

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
AMEDISYS INC [ AMED ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Accounting Officer
3. Date of Earliest Transaction (Month/Day/Year)
07/25/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/25/2025 F 25 D $97.94 7,457 D
Common Stock 1.5(1) I By 401(k) Plan
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The information in this report is based on a plan statement dated as of June 30, 2025.
Remarks:
/s/ Jennifer Guckert Griffin, pursuant to a power of attorney 07/29/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Orrstown (ORRF) shares did EVP Michael Jaeger sell?

He sold 642 common shares on 07/28/2025.

What price did the ORRF shares sell for in this Form 4?

The reported sale price was $34.25 per share.

How many shares does Michael Jaeger own after the transaction?

He now holds 745 unrestricted shares and 4,198 restricted shares.

Were any derivative securities or option exercises reported?

No, the filing lists no derivative acquisitions or exercises.

Does this filing include other Orrstown insiders?

No, the Form 4 covers only Michael Jaeger.
Amedisys Inc

NASDAQ:AMED

AMED Rankings

AMED Latest News

AMED Latest SEC Filings

AMED Stock Data

3.20B
32.18M
2.09%
91.58%
8.81%
Medical Care Facilities
Services-home Health Care Services
United States
BATON ROUGE